Bionic Sight, Inc.
PrivateLast Round
VC Round
Apr 1, 2025
Est. Valuation
$40M
Company Overview
Bionic Sight, Inc. is a biotechnology company developing optogenetic gene therapies and neuro-prosthetic devices to restore sight to patients with retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Computer Vision, Medical Devices, Drug Discovery
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionic Sight, Inc. Comparables
Compare Bionic Sight, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 88% | |
| Nanoscope Therapeutics Inc. | 86% | |
| SparingVision | 83% | |
Bionic Sight, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2025 | ||||
| VC Round | Jan 24, 2017 |
Bionic Sight, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Raptor Group | VC Round |
| Partnership for New York City | VC Round |
| Cornell University Office of University Investments | VC Round |
| Samsara BioCapital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Raised capital from Partnership Fund for New York City.
- Jan 24, 2017
$2M round led by Beacon Therapeutics.
Bionic Sight, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bionic Sight, Inc.'s valuation, stock price, and market status.